Skip to main content
. 2023 Nov 17;14:1195966. doi: 10.3389/fendo.2023.1195966

Table 2.

Risk prediction of complements for DKD at different stages.

Significant risk factors G1 G 2 G 3 G 4 G 5
C3 (+0.1 g/L) Ref. 0.956, 0.910 to 1.003, p=0.068 0.885, 0.842 to 0.931, p<0.001 0.822, 0.767 to 0.880, p<0.001 0.646, 0.598 to 0.698, P<0.001
C4 (+0.1 g/L) Ref. 1.323,1.132 to 1.546, P<0.001 1.627, 1.395 to 1.897, p<0.001 1.839, 1.521 to 2.224, p<0.001 1.689, 1.407 to 2.027, P<0.001
C1q (+10mg/L) Ref. 1.044, 1.000 to 1.090, P=0.049 1.039, 0.998 to 1.082, p=0.063 1.041, 0.987 to 1.098, P=0.142 1.030, 0.978 to 1.084, P=0.261
After propensity score matching for age, gender, SBP, HbA1C, TG and ACR
C3 (+0.1 g/L) Ref. 1.079, 1.000 to 1.160, P=0.038 0.960, 0.885 to 1.041, P=0.322 0.911, 0.813 to 1.021, P=0.110 0.722, 0.616 to 0.847, P<0.001
C4 (+0.1 g/L) Ref. 1.830, 1.436 to 2.332, P<0.001 1.860, 1.433 to 2.413, P<0.001 1.879, 1.291 to 2.735, P=0.001 2.776, 1.670 to 4.610, P<0.001
C1q (+10 mg/L) Ref. 1.038, 0.973 to 1.107, P=0.256 1.100, 1.022 to 1.183, P=0.011 1.101, 0.997 to 1.216, P=0.058 1.123, 0.973 to 1.296, P=0.111

C3, Complement 3; C4, Complement 4; C1q, Complement 1q. Data are expressed as odds ratio, 95% confidence interval, P value.